Early diagnosis and appropriate treatment of infections in cirrhosis are crucial due to their high morbidity and mortality. Multidrug-resistant (MDR) infections are on the increase in healthcare settings. Healthcare-associated (HCA) infections are still frequently treated as community-acquired with a detrimental effect on survival. We aimed to prospectively evaluate in a randomized trial the effectiveness of a Broad Spectrum antibiotic treatment in cirrhotic patients with HCA infections. Consecutive cirrhotic patients hospitalized with HCA infections were enrolled. After culture sampling, patients were promptly randomized to receive a Standard or a Broad Spectrum antibiotic treatment (NCT01820026). The primary endpoint was in-hospital mortality. Efficacy, side effects and the length of hospitalization were considered. Treatment failure was followed by a change in antibiotic therapy. Ninety-six patients were randomized and 94 were included. The two groups were similar for demographic, clinical and microbiological characteristics. The prevalence of MDR pathogens was 40% in the Standard vs 46% in the Broad Spectrum group. In-hospital mortality showed a substantial reduction in the Broad Spectrum vs Standard group (6 vs 25%, p=0.01). In a post-hoc analysis the reduction of mortality was more evident in patients with sepsis. The Broad Spectrum showed a lower rate of treatment failure than the Standard therapy (18 vs 51%, p=0.001). The length of hospitalization was shorter in the Broad Spectrum (12.3 ± 7 days) vs Standard group (18 ± 15 days) (p= 0.03). Five patients in each group developed a second infection during hospitalization with a similar prevalence of MDR (50% Broad Spectrum vs 60% Standard).

An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics. A randomized trial / Merli, Manuela; Lucidi, Cristina; DI GREGORIO, Vincenza; Lattanzi, Barbara; Giannelli, Valerio; Giusto, Michela; Farcomeni, Alessio; Ceccarelli, Giancarlo; Falcone, Marco; Riggio, Oliviero; Venditti, Mario. - In: HEPATOLOGY. - ISSN 0270-9139. - STAMPA. - (2016), pp. 1-7. [10.1002/hep.28332]

An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics. A randomized trial

MERLI, Manuela;GIUSTO, MICHELA;FARCOMENI, Alessio;CECCARELLI, GIANCARLO;FALCONE, MARCO;RIGGIO, Oliviero;VENDITTI, Mario
2016

Abstract

Early diagnosis and appropriate treatment of infections in cirrhosis are crucial due to their high morbidity and mortality. Multidrug-resistant (MDR) infections are on the increase in healthcare settings. Healthcare-associated (HCA) infections are still frequently treated as community-acquired with a detrimental effect on survival. We aimed to prospectively evaluate in a randomized trial the effectiveness of a Broad Spectrum antibiotic treatment in cirrhotic patients with HCA infections. Consecutive cirrhotic patients hospitalized with HCA infections were enrolled. After culture sampling, patients were promptly randomized to receive a Standard or a Broad Spectrum antibiotic treatment (NCT01820026). The primary endpoint was in-hospital mortality. Efficacy, side effects and the length of hospitalization were considered. Treatment failure was followed by a change in antibiotic therapy. Ninety-six patients were randomized and 94 were included. The two groups were similar for demographic, clinical and microbiological characteristics. The prevalence of MDR pathogens was 40% in the Standard vs 46% in the Broad Spectrum group. In-hospital mortality showed a substantial reduction in the Broad Spectrum vs Standard group (6 vs 25%, p=0.01). In a post-hoc analysis the reduction of mortality was more evident in patients with sepsis. The Broad Spectrum showed a lower rate of treatment failure than the Standard therapy (18 vs 51%, p=0.001). The length of hospitalization was shorter in the Broad Spectrum (12.3 ± 7 days) vs Standard group (18 ± 15 days) (p= 0.03). Five patients in each group developed a second infection during hospitalization with a similar prevalence of MDR (50% Broad Spectrum vs 60% Standard).
2016
antibiotic therapy; bacterial infection; cirrhosis; sepsis; treatment failure
01 Pubblicazione su rivista::01a Articolo in rivista
An empirical broad spectrum antibiotic therapy in Healthcare-Associated infections improves survival in cirrhotics. A randomized trial / Merli, Manuela; Lucidi, Cristina; DI GREGORIO, Vincenza; Lattanzi, Barbara; Giannelli, Valerio; Giusto, Michela; Farcomeni, Alessio; Ceccarelli, Giancarlo; Falcone, Marco; Riggio, Oliviero; Venditti, Mario. - In: HEPATOLOGY. - ISSN 0270-9139. - STAMPA. - (2016), pp. 1-7. [10.1002/hep.28332]
File allegati a questo prodotto
File Dimensione Formato  
Merli_empirical-broad-spectrum_2016.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 184.65 kB
Formato Adobe PDF
184.65 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/846506
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 53
social impact